|
Volumn 35, Issue 6, 2003, Pages 2199-2201
|
Human herpesvirus-6 in renal transplant recipients: Potential risk factors for the development of human herpesvirus-6 seroconversion
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DACLIZUMAB;
IMMUNOGLOBULIN G ANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
RAPAMYCIN;
ADULT;
AGED;
CONFERENCE PAPER;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GRAFT REJECTION;
HUMAN;
HUMAN HERPESVIRUS 6;
IMMUNOFLUORESCENCE;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RISK FACTOR;
SAMPLING;
SEROCONVERSION;
SEROLOGY;
STATISTICAL SIGNIFICANCE;
VIRUS INFECTION;
|
EID: 12444339426
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(03)00792-9 Document Type: Conference Paper |
Times cited : (16)
|
References (15)
|